TransMedics (TMDX) Cash & Current Investments (2018 - 2026)

TransMedics' Cash & Current Investments history runs 9 years deep, the most recent figure standing at $461.7 million for Q1 2026.

• In Q1 2026, Cash & Current Investments rose 48.87% year-over-year to $461.7 million; the TTM figure through Mar 2026 stood at $461.7 million (up 48.87% YoY), while the FY2025 annual figure was $488.4 million, up 45.07% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $461.7 million, down from $488.4 million in the prior quarter.
• The five-year high for Cash & Current Investments was $582.2 million in Q2 2023, with the low at $58.1 million in Q2 2022.
• The 5-year median for Cash & Current Investments is $350.2 million (2024), against an average of $334.6 million.
• The sharpest annual moves came in 2022 and 2023: Cash & Current Investments sank 48.26% in 2022, then soared 902.38% in 2023.
• TransMedics' Cash & Current Investments stood at $201.2 million in 2022, then jumped by 96.25% to $394.8 million in 2023, then declined by 14.73% to $336.6 million in 2024, then soared by 45.07% to $488.4 million in 2025, then declined by 5.46% to $461.7 million in 2026.
• Business Quant data shows TMDX's Cash & Current Investments at $461.7 million in Q1 2026, $488.4 million in Q4 2025, and $466.2 million in Q3 2025.